Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsReligare cap mkts

    Religare Cap Mkts

    Jump to
    • Bullish on Lupin, Aurobindo; cautious on Ranbaxy: Religare

      Bullish on Lupin, Aurobindo; cautious on Ranbaxy: Religare

      Arvind Bothra, vice president of institutional research at Religare Capital Markets is cautious on Ranbaxy because the earnings visibility is very low and believes that the expectations of a turnaround in the US business etc are seemingly priced-in the stock.

    • Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra

      Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra

      Arvind Bothra, vice president of institutional research at Religare Capital Markets says Lupin, Sun Pharmaceutical Industries and Dr Reddy's are top picks in the pharma space.

    • Arvind Bothra positive on Aurobindo Pharma

      Arvind Bothra positive on Aurobindo Pharma

      Arvind Bothra, vice president of institutional research at Religare Capital Markets is positive on Aurobindo Pharma. "Its US business is continuing to do exceedingly well, both on execution of product launches as well as the quality of product approvals," he adds.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347